Emergo Therapeutics is a biopharmaceutical company specializing in developing drugs to modulate inflammatory cytokines. It aims to improve the functioning of the immune system in various potential indications, starting with infectious diseases. The company is focused on reducing the production of inflammatory cytokines from mast cells.